Resultados de la búsqueda 541-550 of 14928 for Dr. Sunanda Kane

1. Neurología - Ensayos clínicos - Mayo Clinic

   ... Dr. Gendler). Eligibility Criteria, keep current Eligibility Criteria, but precede by:: "Three cohorts of patients will be collected.:Cohort 1 includes (1) ...

2. Medicina Interna Hospitalaria - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to identify important physiologic trends in bedside ICU data such as cerebral perfusion pressure (CPP), intracranial pressure (ICP) ...

3. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to combine recent advances in ultrasound imaging, specifically an endonasal transducer array and contrast enhanced ultrasound, ...

4. Neurología - Ensayos clínicos - Mayo Clinic

   ... Dr. Gendler). Eligibility Criteria, keep current Eligibility Criteria, but precede by:: "Three cohorts of patients will be collected.:Cohort 1 includes (1) ...

5. Neurología - Ensayos clínicos - Mayo Clinic

   ... Dr. Gendler). Eligibility Criteria, keep current Eligibility Criteria, but precede by:: "Three cohorts of patients will be collected.:Cohort 1 includes (1) ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...

7. Neurología - Ensayos clínicos - Mayo Clinic

   ... Dr. Gendler). Eligibility Criteria, keep current Eligibility Criteria, but precede by:: "Three cohorts of patients will be collected.:Cohort 1 includes (1) ...

8. Enfermedad intestinal inflamatoria - Médicos y departamentos - Mayo Clinic

   Kane, Sunanda V. M.D.. Minnesota. Klinkner, Denise B. M.D., M.Ed. Minnesota ... Dr. Joseph Sirven, profesor de Neurología, Mayo Clinic: La misión de Mayo ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...